Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 46, 2013, Pages 18537-18542

  Portal, Daniel ^a,b   Zhou, Hufeng ^a,b,c   Zhao, Bo ^a,b   Kharchenko, Peter V ^d   Lowry, Elizabeth ^a,b   Wong, Limsoon ^c   Quackenbush, John ^e   Holloway, Dustin ^e   Jiang, Sizun ^a,b,d   Lu, Yong ^f   Kieff, Elliott ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d Harvard Medical School Center for Biomedical Informatics   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Gene expression; Genome wide ChIP seq analysis

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 2; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN LEADER PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; MYC PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BATF; TRANSCRIPTION FACTOR CTCF; TRANSCRIPTION FACTOR EBF; TRANSCRIPTION FACTOR ETS1; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR RAD21; TRANSCRIPTION FACTOR RBPJ; TRANSCRIPTION FACTOR SMC3; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR TBLR; TRANSCRIPTION FACTOR YY1; TRANSCRIPTION FACTOR ZNF143; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENHANCER REGION; GENE CONTROL; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION SITE;

GENE EXPRESSION; GENOME-WIDE CHIP-SEQ ANALYSIS;

ANIMALS; B-LYMPHOCYTES; CALLITHRIX; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CLUSTER ANALYSIS; ENHANCER ELEMENTS, GENETIC; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS; VIRAL PROTEINS;

EID: 84887443059     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1317608110     Document Type: Article

References (59)

1. Cohen JI, Kieff E (1991) An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator. J Virol 65(11):5880-5885.
2. Cohen JI, Wang F, Kieff E (1991) Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J Virol 65(5):2545-2554.
3. Cohen JI, Wang F, Mannick J, Kieff E (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci USA 86(23):9558-9562. (Pubitemid 20010466)
4. Mannick JB, Cohen JI, Birkenbach M, Marchini A, Kieff E (1991) The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol 65(12):6826-6837.
5. Dambaugh T, Hennessy K, Chamnankit L, Kieff E (1984) U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 81(23):7632-7636.
6. Dambaugh T, et al. (1986) Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells. J Virol 59(2):453-462. (Pubitemid 16013994)
7. Wang F, Petti L, Braun D, Seung S, Kieff E (1987) A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes. J Virol 61(4):945-954. (Pubitemid 17044002)
8. Ling PD, et al. (2005) Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. EMBO J 24(20):3565-3575. (Pubitemid 41509364)
9. Portal D, et al. (2011) EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Proc Natl Acad Sci USA 108(19):7808-7813.
10. Portal D, Rosendorff A, Kieff E (2006) Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4. Proc Natl Acad Sci USA 103(51):19278-19283. (Pubitemid 46026024)
11. Han I, et al. (2002) Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins. Mol Cell Biol 22(7):2136-2146. (Pubitemid 34224621)
12. Han I, et al. (2001) EBNA-LP associates with cellular proteins including DNA-PK and HA95. J Virol 75(5):2475-2481. (Pubitemid 32147588)
13. Harada S, Kieff E (1997) Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation. J Virol 71(9):6611-6618. (Pubitemid 27355319)
14. Alfieri C, Birkenbach M, Kieff E (1991) Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181(2):595-608.
15. Mannick JB, Tong X, Hemnes A, Kieff E (1995) The Epstein-Barr virus nuclear antigen leader protein associates with hsp72/hsc73. J Virol 69(12):8169-8172.
16. Peng CW, et al. (2007) Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2. Blood 109(12):5447-5454.
17. Zhao B, et al. (2011) Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Natl Acad Sci USA 108(36):14902-14907.
18. Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E (1994) The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad Sci USA 91(16):7568-7572.
19. Henkel T, Ling PD, Hayward SD, Peterson MG (1994) Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265(5168):92-95.
20. Tong X, Wang F, Thut CJ, Kieff E (1995) The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein. J Virol 69(1):585-588. (Pubitemid 24378845)
21. Tong X, Drapkin R, Yalamanchili R, Mosialos G, Kieff E (1995) The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol Cell Biol 15(9):4735-4744.
22. Nikitin PA, et al. (2010) An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells. Cell Host Microbe 8(6):510-522.
23. Peng R, Tan J, Ling PD (2000) Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2. J Virol 74(21):9953-9963.
24. Peng R, Moses SC, Tan J, Kremmer E, Ling PD (2005) The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter. J Virol 79(7):4492-4505. (Pubitemid 40388386)
25. Phillips JE, Corces VG (2009) CTCF: Master weaver of the genome. Cell 137(7):1194-1211.
26. Merkenschlager M, Odom DT (2013) CTCF and cohesin: Linking gene regulatory elements with their targets. Cell 152(6):1285-1297.
27. Remeseiro S, Cuadrado A, Gómez-López G, Pisano DG, Losada A (2012) A unique role of cohesin-SA1 in gene regulation and development. EMBO J 31(9):2090-2102.
28. Cuadrado A, Remeseiro S, Gómez-López G, Pisano DG, Losada A (2012) The specific contributions of cohesin-SA1 to cohesion and gene expression: Implications for cancer and development. Cell Cycle 11(12):2233-2238.
29. Degner SC, et al. (2011) CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cells. Proc Natl Acad Sci USA 108(23):9566-9571.
30. Degner SC, Wong TP, Jankevicius G, Feeney AJ (2009) Cutting edge: Developmental stage-specific recruitment of cohesin to CTCF sites throughout immunoglobulin loci during B lymphocyte development. J Immunol 182(1):44-48.
31. Herold M, Bartkuhn M, Renkawitz R (2012) CTCF: Insights into insulator function during development. Development 139(6):1045-1057.
32. Chaumeil J, Skok JA (2012) The role of CTCF in regulating V(D)J recombination. Curr Opin Immunol 24(2):153-159.
33. Gillen AE, Harris A (2011) The role of CTCF in coordinating the expression of single gene loci. Biochem Cell Biol 89(5):489-494.
34. Rhodes JM, et al. (2010) Positive regulation of c-Myc by cohesin is direct, and evolutionarily conserved. Dev Biol 344(2):637-649.
35. Dorsett D, Merkenschlager M (2013) Cohesin at active genes: A unifying theme for cohesin and gene expression from model organisms to humans. Curr Opin Cell Biol 25(3):327-333.
36. Dorsett D (2011) Cohesin: Genomic insights into controlling gene transcription and development. Curr Opin Genet Dev 21(2):199-206.
37. Hou C, Zhao H, Tanimoto K, Dean A (2008) CTCF-dependent enhancer-blocking by alternative chromatin loop formation. Proc Natl Acad Sci USA 105(51):20398-20403.
38. Splinter E, et al. (2006) CTCF mediates long-range chromatin looping and local histone modification in the beta-globin locus. Genes Dev 20(17):2349-2354. (Pubitemid 44320383)
39. Cai Y, et al. (2007) YY1 functions with INO80 to activate transcription. Nat Struct Mol Biol 14(9):872-874. (Pubitemid 47373827)
40. Lin YC, et al. (2012) Global changes in the nuclear positioning of genes and intra- and interdomain genomic interactions that orchestrate B cell fate. Nat Immunol 13(12):1196-1204.
41. Wang H, et al. (2011) Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proc Natl Acad Sci USA 108(36):14908-14913.
42. Halbig KM, Lekven AC, Kunkel GR (2012) The transcriptional activator ZNF143 is essential for normal development in zebrafish. BMC Mol Biol 13:3.
43. Li P, et al. (2012) BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490(7421):543-546.
44. Amouyal M (2010) Gene insulation. Part II: Natural strategies in vertebrates. Biochem Cell Biol 88(6):885-898.
45. Donohoe ME, Silva SS, Pinter SF, Xu N, Lee JT (2009) The pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting. Nature 460(7251):128-132.
46. Perissi V, et al. (2008) TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. Mol Cell 29(6):755-766. (Pubitemid 351400927)
47. Price AM, et al. (2012) Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation. J Virol 86(20):11096-11106.
48. Peng CW, Zhao B, Kieff E (2004) Four EBNA2 domains are important for EBNALP coactivation. J Virol 78(20):11439-11442. (Pubitemid 39299690)
49. Peng CW, et al. (2004) Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation. Proc Natl Acad Sci USA 101(4):1033-1038.
50. Mushinski JF, et al. (1999) Myc-induced cyclin D2 genomic instability in murine B cell neoplasms. Curr Top Microbiol Immunol 246:183-189; discussion 190-192.
51. Bouchard C, et al. (2001) Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 15(16):2042-2047. (Pubitemid 32762047)
52. Sinclair AJ, Palmero I, Holder A, Peters G, Farrell PJ (1995) Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene. J Virol 69(2):1292-1295.
53. Zinkel S, Gross A, Yang E (2006) BCL2 family in DNA damage and cell cycle control. Cell Death Differ 13(8):1351-1359. (Pubitemid 44057470)
54. Harris LK, Westwood M (2012) Biology and significance of signalling pathways activated by IGF-II. Growth Factors 30(1):1-12.
55. Lewis BA, Reinberg D (2003) The mediator coactivator complex: Functional and physical roles in transcriptional regulation. J Cell Sci 116(Pt 18):3667-3675. (Pubitemid 37185296)
56. Maruo S, et al. (2011) Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression. Proc Natl Acad Sci USA 108(5):1919-1924.
57. Rayess H, Wang MB, Srivatsan ES (2012) Cellular senescence and tumor suppressor gene p16. Int J Cancer 130(8):1715-1725.
58. Sinclair AJ, Palmero I, Peters G, Farrell PJ (1994) EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J 13(14):3321-3328. (Pubitemid 24226947)
59. Li Y, et al. (2006) A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. Genes Dev 20(18):2566-2579. (Pubitemid 44396841)